Title: Transforming the treatment of schizophrenia: Design and development of AMPA receptor modulators with a much improved safety profile as novel drugs for treating the cognitive dysfunction associated with schizophrenia and other CNS disorders

University of Sussex,Wellcome Trust

Principal Investigator

Atack, John

Project Details
Net value award figure for Cardiff University: £3,466,448.00
Start date: 01/08/2017
End date: 30/03/2021

Last updated on 2020-08-08 at 06:02